SDS Biotech K.K. reported consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales of ¥2,165 million against ¥4,229 million a year ago. Operating income was ¥448 million against ¥531 million a year ago. Ordinary income was ¥608 million against ¥458 million a year ago. Net income attributable to owners of parent was ¥335 million or ¥42.84 per basic share against ¥320 million or ¥40.92 per basic and diluted share a year ago. Net loss before taxes was ¥607,967,000.

For the fiscal year ending March 31, 2017, the company expects net sales of ¥16,210 million, operating income of ¥1,460 million, ordinary income of ¥1,220 million and net income of ¥820 million or ¥104.71 per share.